Sharma, G.G.; Mota, I.; Mologni, L.; Patrucco, E.; Gambacorti-Passerini, C.; Chiarle, R.
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes. Cancers 2018, 10, 62.
https://doi.org/10.3390/cancers10030062
AMA Style
Sharma GG, Mota I, Mologni L, Patrucco E, Gambacorti-Passerini C, Chiarle R.
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes. Cancers. 2018; 10(3):62.
https://doi.org/10.3390/cancers10030062
Chicago/Turabian Style
Sharma, Geeta Geeta, Ines Mota, Luca Mologni, Enrico Patrucco, Carlo Gambacorti-Passerini, and Roberto Chiarle.
2018. "Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes" Cancers 10, no. 3: 62.
https://doi.org/10.3390/cancers10030062
APA Style
Sharma, G. G., Mota, I., Mologni, L., Patrucco, E., Gambacorti-Passerini, C., & Chiarle, R.
(2018). Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes. Cancers, 10(3), 62.
https://doi.org/10.3390/cancers10030062